| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $19.3M | +0.0% |
| R&D Expense | $56.1M | -7.3% |
| SG&A Expense | $16.4M | -8.2% |
| Operating Income | -$72.5M | -22.8% |
| Pre-tax Income | -$70.8M | -27.6% |
| Income Tax | $37K | +112.9% |
| Net Income | -$70.8M | -28.3% |
| EPS (Basic) | -$3.07 | +35.8% |
| EPS (Diluted) | -$3.07 | +35.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $28.9M | +62.5% |
| Short-term Investments | $0 | -100.0% |
| Accounts Receivable | $0 | -100.0% |
| Current Assets | $34.2M | -66.6% |
| Total Assets | $40.1M | -64.4% |
| Current Liabilities | $8.2M | -31.5% |
| Total Liabilities | $8.7M | -38.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$67.4M | -1.9% |
| Capital Expenditures | $229K | -81.7% |
| Investing Cash Flow | $78.6M | +379.6% |
| Financing Cash Flow | $11K | -100.0% |
| Free Cash Flow | -$67.7M | -0.4% |
| Stockholders' Equity |
| $31.5M |
| -68.1% |